Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication.

Articles from the journal in Anti-Cancer Agents in Medicinal Chemistry, 16 issue 1:

  • Therapeutic Use of MicroRNAs in Cancer
  • The Alkylating-HDAC Inhibition Fusion Principle: Taking Chemotherapy to the Next Level with the First in Class Molecule EDO-S101
  • Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer
  • Targeting Cancer Stem Cells: Promises and Challenges
  • CXCR4 and Glioblastoma
  • Therapeutic Potential of Targeting PAK Signaling
  • Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths?
  • The Immune System in Cancer Prevention, Development and Therapy
  • Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part II: Alkaloids, Terpenoids and Flavonoids
  • Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia

For details on the articles, please visit this link http://bit.ly/1ljMCpv